Gene: KIR2DS3
Official Full Name: killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3provided by HGNC
Gene Summary: Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36941 | KIR2DS3 Knockout cell line (HeLa) | Human | KIR2DS3 | 1:3~1:6 | Negative | Online Inquiry |
KO36942 | KIR2DS3 Knockout cell line (HCT 116) | Human | KIR2DS3 | 1:2~1:4 | Negative | Online Inquiry |
KO36943 | KIR2DS3 Knockout cell line (HEK293) | Human | KIR2DS3 | 1:3~1:6 | Negative | Online Inquiry |
KO36944 | KIR2DS3 Knockout cell line (A549) | Human | KIR2DS3 | 1:3~1:4 | Negative | Online Inquiry |
KIR2DS3 Gene Knockout Cell Lines are genetically engineered cellular models designed to study the effects of the KIR2DS3 gene—part of the killer immunoglobulin-like receptor (KIR) family that plays a critical role in the immune response. By employing CRISPR-Cas9 technology, these cell lines have been successfully modified to disrupt the expression of KIR2DS3, allowing researchers to delve deeper into its biological functions and implications in various immune-mediated processes.
The key function of KIR2DS3 lies in its interaction with specific ligands on target cells, which regulates natural killer (NK) cell activity, thereby influencing immune surveillance and responses to infections or tumors. By utilizing knockout cell lines, scientists can investigate the absence of KIR2DS3’s inhibitory signals, thereby elucidating its regulatory mechanisms within the immune system. This can lead to groundbreaking insights into conditions such as cancer, autoimmune diseases, and transplant rejection.
The scientific importance of KIR2DS3 Gene Knockout Cell Lines is profound; they are valuable tools in both research and clinical settings. In immunotherapy research, understanding how disrupting KIR2DS3 contributes to enhanced NK cell function can yield strategies to improve therapeutic interventions. Furthermore, these cell lines provide a platform to explore the genetic and epigenetic factors that influence patient responses to treatment.
What sets our KIR2DS3 Gene Knockout Cell Lines apart from alternatives on the market is not only their specificity but also their ease of use in diverse applications such as high-throughput screening and functional assays. Researchers benefit from a carefully curated quality control process, ensuring reproducibility and reliability in findings, and thus facilitating the translation of basic research to clinical practice.
Our commitment to advancing the field of immunology through expert-crafted biological products means that our KIR2DS3 Gene Knockout Cell Lines are backed by extensive validation and ongoing support from our knowledgeable team. Whether you are investigating cell signaling pathways or designing cutting-edge therapeutic strategies, our cell lines are integral to achieving a deeper understanding of immune regulation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.